APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nanopore Molecular Sequencing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nanopore Molecular Sequencing Service Market Analysis and Forecast 2026-2032

Report ID 17419549024 June 2026202 pages

Choose your research edition.

Industry ResearchNanopore Molecular Sequencing Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanopore Molecular Sequencing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Nanopore Molecular Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanopore Molecular Sequencing Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanopore Molecular Sequencing Service Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Nanopore Molecular Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nanopore Molecular Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nanopore Molecular Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nanopore Molecular Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nanopore Molecular Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nanopore Molecular Sequencing Service include Azenta Life Sciences, Novogene Co., Ltd., BGI Genomics Co., Ltd., Eurofins Genomics, Plasmidsaurus, Biomarker Technologies Corporation, Macrogen Inc., CD Genomics and Microsynth AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nanopore Molecular Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nanopore Molecular Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanopore Molecular Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanopore Molecular Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanopore Molecular Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanopore Molecular Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

Nanopore Molecular Sequencing Service Segment by Company

Azenta Life Sciences

Novogene Co., Ltd.

BGI Genomics Co., Ltd.

Eurofins Genomics

Plasmidsaurus

Biomarker Technologies Corporation

Macrogen Inc.

CD Genomics

Microsynth AG

BaseClear

Genotypic Technology Pvt. Ltd.

Takara Bio Inc.

FASMAC Co., Ltd.

SeqCenter

SeqCoast Genomics

Wuhan Benagen Tech Co., Ltd.

GenoScreen

IGA Technology

MicrobesNG

Source BioScience

GenXone

PathoSense

AllGenetics

BIOTOOLS Co., Ltd.

GeneBay, Inc.

Seibutsugiken Co., Ltd.

Biofidus

KeyGene

LongSeq Applications

Nanopore Molecular Sequencing Service Segment by Type

Direct DNA Sequencing

Direct RNA Sequencing

cDNA Sequencing (RNA→cDNA)

DNA+RNA Combined Sequencing

Nanopore Molecular Sequencing Service Segment by Application

Life Sciences

Clinical Medicine

Biomedicine

Public Health

Other

Nanopore Molecular Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Molecular Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanopore Molecular Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Molecular Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nanopore Molecular Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nanopore Molecular Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanopore Molecular Sequencing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanopore Molecular Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Direct DNA Sequencing Major Player Table 3. Direct RNA Sequencing Major Player Table 4. cDNA Sequencing (RNA→cDNA) Major Player Table 5. DNA+RNA Combined Sequencing Major Player Table 6. Global Nanopore Molecular Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Life Sciences Major Player Table 8. Clinical Medicine Major Player Table 9. Biomedicine Major Player Table 10. Public Health Major Player Table 11. Other Major Player Table 12. Nanopore Molecular Sequencing Service Industry Trends Table 13. Nanopore Molecular Sequencing Service Industry Drivers Table 14. Nanopore Molecular Sequencing Service Industry Opportunities and Challenges Table 15. Nanopore Molecular Sequencing Service Industry Restraints Table 16. Global Nanopore Molecular Sequencing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Nanopore Molecular Sequencing Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Nanopore Molecular Sequencing Service Market Share by Region (2021-2026) Table 19. Global Nanopore Molecular Sequencing Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Nanopore Molecular Sequencing Service Market Share by Region (2027-2032) Table 21. Global Nanopore Molecular Sequencing Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Nanopore Molecular Sequencing Service Revenue Market Share by Players (2021-2026) Table 23. Global Nanopore Molecular Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Nanopore Molecular Sequencing Service Key Players Headquarters & Area Served Table 25. Global Nanopore Molecular Sequencing Service Players, Product Type & Application Table 26. Global Nanopore Molecular Sequencing Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Nanopore Molecular Sequencing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Nanopore Molecular Sequencing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Nanopore Molecular Sequencing Service Revenue Market Share by Type (2021-2026) Table 33. Global Nanopore Molecular Sequencing Service Revenue Market Share by Type (2027-2032) Table 34. Global Nanopore Molecular Sequencing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Nanopore Molecular Sequencing Service Revenue Market Share by Application (2021-2026) Table 38. Global Nanopore Molecular Sequencing Service Revenue Market Share by Application (2027-2032) Table 39. Azenta Life Sciences Company Information Table 40. Azenta Life Sciences Business Overview Table 41. Azenta Life Sciences Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Azenta Life Sciences Nanopore Molecular Sequencing Service Product Portfolio Table 43. Azenta Life Sciences Recent Development Table 44. Novogene Co., Ltd. Company Information Table 45. Novogene Co., Ltd. Business Overview Table 46. Novogene Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Novogene Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 48. Novogene Co., Ltd. Recent Development Table 49. BGI Genomics Co., Ltd. Company Information Table 50. BGI Genomics Co., Ltd. Business Overview Table 51. BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 53. BGI Genomics Co., Ltd. Recent Development Table 54. Eurofins Genomics Company Information Table 55. Eurofins Genomics Business Overview Table 56. Eurofins Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Eurofins Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 58. Eurofins Genomics Recent Development Table 59. Plasmidsaurus Company Information Table 60. Plasmidsaurus Business Overview Table 61. Plasmidsaurus Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Plasmidsaurus Nanopore Molecular Sequencing Service Product Portfolio Table 63. Plasmidsaurus Recent Development Table 64. Biomarker Technologies Corporation Company Information Table 65. Biomarker Technologies Corporation Business Overview Table 66. Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Product Portfolio Table 68. Biomarker Technologies Corporation Recent Development Table 69. Macrogen Inc. Company Information Table 70. Macrogen Inc. Business Overview Table 71. Macrogen Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Macrogen Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 73. Macrogen Inc. Recent Development Table 74. CD Genomics Company Information Table 75. CD Genomics Business Overview Table 76. CD Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. CD Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 78. CD Genomics Recent Development Table 79. Microsynth AG Company Information Table 80. Microsynth AG Business Overview Table 81. Microsynth AG Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Microsynth AG Nanopore Molecular Sequencing Service Product Portfolio Table 83. Microsynth AG Recent Development Table 84. BaseClear Company Information Table 85. BaseClear Business Overview Table 86. BaseClear Nanopore Molecular Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. BaseClear Nanopore Molecular Sequencing Service Product Portfolio Table 88. BaseClear Recent Development Table 89. Genotypic Technology Pvt. Ltd. Company Information Table 90. Genotypic Technology Pvt. Ltd. Business Overview Table 91. Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 93. Genotypic Technology Pvt. Ltd. Recent Development Table 94. Takara Bio Inc. Company Information Table 95. Takara Bio Inc. Business Overview Table 96. Takara Bio Inc. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Takara Bio Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 98. Takara Bio Inc. Recent Development Table 99. FASMAC Co., Ltd. Company Information Table 100. FASMAC Co., Ltd. Business Overview Table 101. FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 103. FASMAC Co., Ltd. Recent Development Table 104. SeqCenter Company Information Table 105. SeqCenter Business Overview Table 106. SeqCenter Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. SeqCenter Nanopore Molecular Sequencing Service Product Portfolio Table 108. SeqCenter Recent Development Table 109. SeqCoast Genomics Company Information Table 110. SeqCoast Genomics Business Overview Table 111. SeqCoast Genomics Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. SeqCoast Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 113. SeqCoast Genomics Recent Development Table 114. Wuhan Benagen Tech Co., Ltd. Company Information Table 115. Wuhan Benagen Tech Co., Ltd. Business Overview Table 116. Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 118. Wuhan Benagen Tech Co., Ltd. Recent Development Table 119. GenoScreen Company Information Table 120. GenoScreen Business Overview Table 121. GenoScreen Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. GenoScreen Nanopore Molecular Sequencing Service Product Portfolio Table 123. GenoScreen Recent Development Table 124. IGA Technology Company Information Table 125. IGA Technology Business Overview Table 126. IGA Technology Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. IGA Technology Nanopore Molecular Sequencing Service Product Portfolio Table 128. IGA Technology Recent Development Table 129. MicrobesNG Company Information Table 130. MicrobesNG Business Overview Table 131. MicrobesNG Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. MicrobesNG Nanopore Molecular Sequencing Service Product Portfolio Table 133. MicrobesNG Recent Development Table 134. Source BioScience Company Information Table 135. Source BioScience Business Overview Table 136. Source BioScience Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Source BioScience Nanopore Molecular Sequencing Service Product Portfolio Table 138. Source BioScience Recent Development Table 139. GenXone Company Information Table 140. GenXone Business Overview Table 141. GenXone Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. GenXone Nanopore Molecular Sequencing Service Product Portfolio Table 143. GenXone Recent Development Table 144. PathoSense Company Information Table 145. PathoSense Business Overview Table 146. PathoSense Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. PathoSense Nanopore Molecular Sequencing Service Product Portfolio Table 148. PathoSense Recent Development Table 149. AllGenetics Company Information Table 150. AllGenetics Business Overview Table 151. AllGenetics Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. AllGenetics Nanopore Molecular Sequencing Service Product Portfolio Table 153. AllGenetics Recent Development Table 154. BIOTOOLS Co., Ltd. Company Information Table 155. BIOTOOLS Co., Ltd. Business Overview Table 156. BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 158. BIOTOOLS Co., Ltd. Recent Development Table 159. GeneBay, Inc. Company Information Table 160. GeneBay, Inc. Business Overview Table 161. GeneBay, Inc. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. GeneBay, Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 163. GeneBay, Inc. Recent Development Table 164. Seibutsugiken Co., Ltd. Company Information Table 165. Seibutsugiken Co., Ltd. Business Overview Table 166. Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 168. Seibutsugiken Co., Ltd. Recent Development Table 169. Biofidus Company Information Table 170. Biofidus Business Overview Table 171. Biofidus Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Biofidus Nanopore Molecular Sequencing Service Product Portfolio Table 173. Biofidus Recent Development Table 174. KeyGene Company Information Table 175. KeyGene Business Overview Table 176. KeyGene Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 177. KeyGene Nanopore Molecular Sequencing Service Product Portfolio Table 178. KeyGene Recent Development Table 179. LongSeq Applications Company Information Table 180. LongSeq Applications Business Overview Table 181. LongSeq Applications Nanopore Molecular Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 182. LongSeq Applications Nanopore Molecular Sequencing Service Product Portfolio Table 183. LongSeq Applications Recent Development Table 184. North America Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 185. North America Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 186. North America Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 187. North America Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 188. North America Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. North America Nanopore Molecular Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 190. North America Nanopore Molecular Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 191. Europe Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 192. Europe Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 193. Europe Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 194. Europe Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 195. Europe Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Europe Nanopore Molecular Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 197. Europe Nanopore Molecular Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 198. China Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 199. China Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 200. China Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 201. China Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Nanopore Molecular Sequencing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Nanopore Molecular Sequencing Service Revenue by Region (US$ Million) & (2021-2026) Table 208. Asia Nanopore Molecular Sequencing Service Revenue by Region (US$ Million) & (2027-2032) Table 209. SAMEA Nanopore Molecular Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Nanopore Molecular Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Nanopore Molecular Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Nanopore Molecular Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. SAMEA Nanopore Molecular Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 215. SAMEA Nanopore Molecular Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Nanopore Molecular Sequencing Service Image Figure 2. Global Nanopore Molecular Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanopore Molecular Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Direct DNA Sequencing Image Figure 5. Direct RNA Sequencing Image Figure 6. cDNA Sequencing (RNA→cDNA) Image Figure 7. DNA+RNA Combined Sequencing Image Figure 8. Global Nanopore Molecular Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nanopore Molecular Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Life Sciences Image Figure 11. Clinical Medicine Image Figure 12. Biomedicine Image Figure 13. Public Health Image Figure 14. Other Image Figure 15. Global Nanopore Molecular Sequencing Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Nanopore Molecular Sequencing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Nanopore Molecular Sequencing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Nanopore Molecular Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nanopore Molecular Sequencing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nanopore Molecular Sequencing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nanopore Molecular Sequencing Service Revenue Market Share by Type (2021-2032) Figure 23. Global Nanopore Molecular Sequencing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nanopore Molecular Sequencing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Nanopore Molecular Sequencing Service Revenue Market Share by Application (2021-2032) Figure 26. North America Nanopore Molecular Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032) Figure 28. North America Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032) Figure 29. North America Nanopore Molecular Sequencing Service Revenue Share by Country (2021-2032) Figure 30. United States Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Nanopore Molecular Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032) Figure 35. Europe Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032) Figure 36. Europe Nanopore Molecular Sequencing Service Revenue Share by Country (2021-2032) Figure 37. Germany Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Nanopore Molecular Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032) Figure 47. China Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032) Figure 48. Asia Nanopore Molecular Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032) Figure 50. Asia Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032) Figure 51. Asia Nanopore Molecular Sequencing Service Revenue Share by Region (2021-2032) Figure 52. Japan Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Nanopore Molecular Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Nanopore Molecular Sequencing Service Revenue Share by Country (2021-2032) Figure 62. Brazil Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Nanopore Molecular Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Direct DNA Sequencing
  • Direct RNA Sequencing
  • cDNA Sequencing (RNA→cDNA)
  • DNA+RNA Combined Sequencing
Applications
  • Life Sciences
  • Clinical Medicine
  • Biomedicine
  • Public Health
  • Other
Companies covered
  • Azenta Life Sciences
  • Novogene Co., Ltd.
  • BGI Genomics Co., Ltd.
  • Eurofins Genomics
  • Plasmidsaurus
  • Biomarker Technologies Corporation
  • Macrogen Inc.
  • CD Genomics
  • Microsynth AG
  • BaseClear
  • Genotypic Technology Pvt. Ltd.
  • Takara Bio Inc.
  • FASMAC Co., Ltd.
  • SeqCenter
  • SeqCoast Genomics
  • Wuhan Benagen Tech Co., Ltd.
  • GenoScreen
  • IGA Technology
  • MicrobesNG
  • Source BioScience
  • GenXone
  • PathoSense
  • AllGenetics
  • BIOTOOLS Co., Ltd.
  • GeneBay, Inc.
  • Seibutsugiken Co., Ltd.
  • Biofidus
  • KeyGene
  • LongSeq Applications

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nanopore Molecular Sequencing Service Market by Type
  3. 1.2.1 Global Nanopore Molecular Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Direct DNA Sequencing
  5. 1.2.3 Direct RNA Sequencing
  6. 1.2.4 cDNA Sequencing (RNA→cDNA)
  7. 1.2.5 DNA+RNA Combined Sequencing
  8. 1.3 Nanopore Molecular Sequencing Service Market by Application
  9. 1.3.1 Global Nanopore Molecular Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Life Sciences
  11. 1.3.3 Clinical Medicine
  12. 1.3.4 Biomedicine
  13. 1.3.5 Public Health
  14. 1.3.6 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Nanopore Molecular Sequencing Service Market Dynamics
  1. 2.1 Nanopore Molecular Sequencing Service Industry Trends
  2. 2.2 Nanopore Molecular Sequencing Service Industry Drivers
  3. 2.3 Nanopore Molecular Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Nanopore Molecular Sequencing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nanopore Molecular Sequencing Service Market Perspective (2021-2032)
  2. 3.2 Global Nanopore Molecular Sequencing Service Growth Trends by Region
  3. 3.2.1 Global Nanopore Molecular Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nanopore Molecular Sequencing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Nanopore Molecular Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nanopore Molecular Sequencing Service Revenue by Players
  2. 4.1.1 Global Nanopore Molecular Sequencing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Nanopore Molecular Sequencing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nanopore Molecular Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nanopore Molecular Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nanopore Molecular Sequencing Service Key Players Headquarters & Area Served
  7. 4.4 Global Nanopore Molecular Sequencing Service Players, Product Type & Application
  8. 4.5 Global Nanopore Molecular Sequencing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nanopore Molecular Sequencing Service Market CR5 and HHI
  11. 4.6.3 2025 Nanopore Molecular Sequencing Service Tier 1, Tier 2, and Tier 3
5 Nanopore Molecular Sequencing Service Market Size by Type
  1. 5.1 Global Nanopore Molecular Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 5.3 Global Nanopore Molecular Sequencing Service Revenue Market Share by Type (2021-2032)
6 Nanopore Molecular Sequencing Service Market Size by Application
  1. 6.1 Global Nanopore Molecular Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  3. 6.3 Global Nanopore Molecular Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Azenta Life Sciences
  2. 7.1.1 Azenta Life Sciences Company Information
  3. 7.1.2 Azenta Life Sciences Business Overview
  4. 7.1.3 Azenta Life Sciences Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Azenta Life Sciences Nanopore Molecular Sequencing Service Product Portfolio
  6. 7.1.5 Azenta Life Sciences Recent Developments
  7. 7.2 Novogene Co., Ltd.
  8. 7.2.1 Novogene Co., Ltd. Company Information
  9. 7.2.2 Novogene Co., Ltd. Business Overview
  10. 7.2.3 Novogene Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novogene Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  12. 7.2.5 Novogene Co., Ltd. Recent Developments
  13. 7.3 BGI Genomics Co., Ltd.
  14. 7.3.1 BGI Genomics Co., Ltd. Company Information
  15. 7.3.2 BGI Genomics Co., Ltd. Business Overview
  16. 7.3.3 BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  18. 7.3.5 BGI Genomics Co., Ltd. Recent Developments
  19. 7.4 Eurofins Genomics
  20. 7.4.1 Eurofins Genomics Company Information
  21. 7.4.2 Eurofins Genomics Business Overview
  22. 7.4.3 Eurofins Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eurofins Genomics Nanopore Molecular Sequencing Service Product Portfolio
  24. 7.4.5 Eurofins Genomics Recent Developments
  25. 7.5 Plasmidsaurus
  26. 7.5.1 Plasmidsaurus Company Information
  27. 7.5.2 Plasmidsaurus Business Overview
  28. 7.5.3 Plasmidsaurus Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Plasmidsaurus Nanopore Molecular Sequencing Service Product Portfolio
  30. 7.5.5 Plasmidsaurus Recent Developments
  31. 7.6 Biomarker Technologies Corporation
  32. 7.6.1 Biomarker Technologies Corporation Company Information
  33. 7.6.2 Biomarker Technologies Corporation Business Overview
  34. 7.6.3 Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Product Portfolio
  36. 7.6.5 Biomarker Technologies Corporation Recent Developments
  37. 7.7 Macrogen Inc.
  38. 7.7.1 Macrogen Inc. Company Information
  39. 7.7.2 Macrogen Inc. Business Overview
  40. 7.7.3 Macrogen Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Macrogen Inc. Nanopore Molecular Sequencing Service Product Portfolio
  42. 7.7.5 Macrogen Inc. Recent Developments
  43. 7.8 CD Genomics
  44. 7.8.1 CD Genomics Company Information
  45. 7.8.2 CD Genomics Business Overview
  46. 7.8.3 CD Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CD Genomics Nanopore Molecular Sequencing Service Product Portfolio
  48. 7.8.5 CD Genomics Recent Developments
  49. 7.9 Microsynth AG
  50. 7.9.1 Microsynth AG Company Information
  51. 7.9.2 Microsynth AG Business Overview
  52. 7.9.3 Microsynth AG Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Microsynth AG Nanopore Molecular Sequencing Service Product Portfolio
  54. 7.9.5 Microsynth AG Recent Developments
  55. 7.10 BaseClear
  56. 7.10.1 BaseClear Company Information
  57. 7.10.2 BaseClear Business Overview
  58. 7.10.3 BaseClear Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BaseClear Nanopore Molecular Sequencing Service Product Portfolio
  60. 7.10.5 BaseClear Recent Developments
  61. 7.11 Genotypic Technology Pvt. Ltd.
  62. 7.11.1 Genotypic Technology Pvt. Ltd. Company Information
  63. 7.11.2 Genotypic Technology Pvt. Ltd. Business Overview
  64. 7.11.3 Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  66. 7.11.5 Genotypic Technology Pvt. Ltd. Recent Developments
  67. 7.12 Takara Bio Inc.
  68. 7.12.1 Takara Bio Inc. Company Information
  69. 7.12.2 Takara Bio Inc. Business Overview
  70. 7.12.3 Takara Bio Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Takara Bio Inc. Nanopore Molecular Sequencing Service Product Portfolio
  72. 7.12.5 Takara Bio Inc. Recent Developments
  73. 7.13 FASMAC Co., Ltd.
  74. 7.13.1 FASMAC Co., Ltd. Company Information
  75. 7.13.2 FASMAC Co., Ltd. Business Overview
  76. 7.13.3 FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  78. 7.13.5 FASMAC Co., Ltd. Recent Developments
  79. 7.14 SeqCenter
  80. 7.14.1 SeqCenter Company Information
  81. 7.14.2 SeqCenter Business Overview
  82. 7.14.3 SeqCenter Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SeqCenter Nanopore Molecular Sequencing Service Product Portfolio
  84. 7.14.5 SeqCenter Recent Developments
  85. 7.15 SeqCoast Genomics
  86. 7.15.1 SeqCoast Genomics Company Information
  87. 7.15.2 SeqCoast Genomics Business Overview
  88. 7.15.3 SeqCoast Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 SeqCoast Genomics Nanopore Molecular Sequencing Service Product Portfolio
  90. 7.15.5 SeqCoast Genomics Recent Developments
  91. 7.16 Wuhan Benagen Tech Co., Ltd.
  92. 7.16.1 Wuhan Benagen Tech Co., Ltd. Company Information
  93. 7.16.2 Wuhan Benagen Tech Co., Ltd. Business Overview
  94. 7.16.3 Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  96. 7.16.5 Wuhan Benagen Tech Co., Ltd. Recent Developments
  97. 7.17 GenoScreen
  98. 7.17.1 GenoScreen Company Information
  99. 7.17.2 GenoScreen Business Overview
  100. 7.17.3 GenoScreen Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 GenoScreen Nanopore Molecular Sequencing Service Product Portfolio
  102. 7.17.5 GenoScreen Recent Developments
  103. 7.18 IGA Technology
  104. 7.18.1 IGA Technology Company Information
  105. 7.18.2 IGA Technology Business Overview
  106. 7.18.3 IGA Technology Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 IGA Technology Nanopore Molecular Sequencing Service Product Portfolio
  108. 7.18.5 IGA Technology Recent Developments
  109. 7.19 MicrobesNG
  110. 7.19.1 MicrobesNG Company Information
  111. 7.19.2 MicrobesNG Business Overview
  112. 7.19.3 MicrobesNG Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MicrobesNG Nanopore Molecular Sequencing Service Product Portfolio
  114. 7.19.5 MicrobesNG Recent Developments
  115. 7.20 Source BioScience
  116. 7.20.1 Source BioScience Company Information
  117. 7.20.2 Source BioScience Business Overview
  118. 7.20.3 Source BioScience Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Source BioScience Nanopore Molecular Sequencing Service Product Portfolio
  120. 7.20.5 Source BioScience Recent Developments
  121. 7.21 GenXone
  122. 7.21.1 GenXone Company Information
  123. 7.21.2 GenXone Business Overview
  124. 7.21.3 GenXone Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 GenXone Nanopore Molecular Sequencing Service Product Portfolio
  126. 7.21.5 GenXone Recent Developments
  127. 7.22 PathoSense
  128. 7.22.1 PathoSense Company Information
  129. 7.22.2 PathoSense Business Overview
  130. 7.22.3 PathoSense Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 PathoSense Nanopore Molecular Sequencing Service Product Portfolio
  132. 7.22.5 PathoSense Recent Developments
  133. 7.23 AllGenetics
  134. 7.23.1 AllGenetics Company Information
  135. 7.23.2 AllGenetics Business Overview
  136. 7.23.3 AllGenetics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 AllGenetics Nanopore Molecular Sequencing Service Product Portfolio
  138. 7.23.5 AllGenetics Recent Developments
  139. 7.24 BIOTOOLS Co., Ltd.
  140. 7.24.1 BIOTOOLS Co., Ltd. Company Information
  141. 7.24.2 BIOTOOLS Co., Ltd. Business Overview
  142. 7.24.3 BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  144. 7.24.5 BIOTOOLS Co., Ltd. Recent Developments
  145. 7.25 GeneBay, Inc.
  146. 7.25.1 GeneBay, Inc. Company Information
  147. 7.25.2 GeneBay, Inc. Business Overview
  148. 7.25.3 GeneBay, Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  149. 7.25.4 GeneBay, Inc. Nanopore Molecular Sequencing Service Product Portfolio
  150. 7.25.5 GeneBay, Inc. Recent Developments
  151. 7.26 Seibutsugiken Co., Ltd.
  152. 7.26.1 Seibutsugiken Co., Ltd. Company Information
  153. 7.26.2 Seibutsugiken Co., Ltd. Business Overview
  154. 7.26.3 Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  156. 7.26.5 Seibutsugiken Co., Ltd. Recent Developments
  157. 7.27 Biofidus
  158. 7.27.1 Biofidus Company Information
  159. 7.27.2 Biofidus Business Overview
  160. 7.27.3 Biofidus Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Biofidus Nanopore Molecular Sequencing Service Product Portfolio
  162. 7.27.5 Biofidus Recent Developments
  163. 7.28 KeyGene
  164. 7.28.1 KeyGene Company Information
  165. 7.28.2 KeyGene Business Overview
  166. 7.28.3 KeyGene Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  167. 7.28.4 KeyGene Nanopore Molecular Sequencing Service Product Portfolio
  168. 7.28.5 KeyGene Recent Developments
  169. 7.29 LongSeq Applications
  170. 7.29.1 LongSeq Applications Company Information
  171. 7.29.2 LongSeq Applications Business Overview
  172. 7.29.3 LongSeq Applications Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  173. 7.29.4 LongSeq Applications Nanopore Molecular Sequencing Service Product Portfolio
  174. 7.29.5 LongSeq Applications Recent Developments
8 North America
  1. 8.1 North America Nanopore Molecular Sequencing Service Revenue (2021-2032)
  2. 8.2 North America Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Nanopore Molecular Sequencing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Nanopore Molecular Sequencing Service Revenue by Type (2027-2032)
  5. 8.3 North America Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Nanopore Molecular Sequencing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Nanopore Molecular Sequencing Service Revenue by Application (2027-2032)
  9. 8.5 North America Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Nanopore Molecular Sequencing Service Revenue by Country
  11. 8.6.1 North America Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nanopore Molecular Sequencing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Nanopore Molecular Sequencing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nanopore Molecular Sequencing Service Revenue (2021-2032)
  2. 9.2 Europe Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nanopore Molecular Sequencing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nanopore Molecular Sequencing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nanopore Molecular Sequencing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nanopore Molecular Sequencing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nanopore Molecular Sequencing Service Revenue by Country
  11. 9.6.1 Europe Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nanopore Molecular Sequencing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nanopore Molecular Sequencing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nanopore Molecular Sequencing Service Revenue (2021-2032)
  2. 10.2 China Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Nanopore Molecular Sequencing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Nanopore Molecular Sequencing Service Revenue by Type (2027-2032)
  5. 10.3 China Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Nanopore Molecular Sequencing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Nanopore Molecular Sequencing Service Revenue by Application (2027-2032)
  9. 10.5 China Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nanopore Molecular Sequencing Service Revenue (2021-2032)
  2. 11.2 Asia Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nanopore Molecular Sequencing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nanopore Molecular Sequencing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nanopore Molecular Sequencing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nanopore Molecular Sequencing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nanopore Molecular Sequencing Service Revenue by Country
  11. 11.6.1 Asia Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nanopore Molecular Sequencing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nanopore Molecular Sequencing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nanopore Molecular Sequencing Service Revenue (2021-2032)
  2. 12.2 SAMEA Nanopore Molecular Sequencing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nanopore Molecular Sequencing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nanopore Molecular Sequencing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nanopore Molecular Sequencing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nanopore Molecular Sequencing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nanopore Molecular Sequencing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nanopore Molecular Sequencing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nanopore Molecular Sequencing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nanopore Molecular Sequencing Service Revenue by Country
  11. 12.6.1 SAMEA Nanopore Molecular Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nanopore Molecular Sequencing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nanopore Molecular Sequencing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst